March 28, 2025 - 10:56

Financial services companies are still in the early stages of deploying generative and agentic artificial intelligence (AI), despite the growing discussions surrounding its potential. A recent roundtable hosted by the SEC highlighted the industry's cautious approach to integrating AI technologies. While the promise of AI in enhancing efficiency, risk management, and customer service is enticing, many firms are grappling with the practical challenges of implementation.
Regulatory concerns and the need for robust risk management frameworks are significant factors influencing this cautious stance. Participants at the roundtable expressed that while AI can transform operations, it also raises issues related to compliance, data privacy, and ethical considerations. The need for transparency in AI decision-making processes was emphasized, as stakeholders seek to ensure that AI systems are fair and accountable.
As financial institutions navigate these complexities, the focus remains on balancing innovation with regulatory obligations, aiming to harness AI's capabilities while safeguarding consumer interests and maintaining market stability.
June 23, 2026 - 20:50
Bitcoin 'vulnerable to further weakness' as token tumbles amid tech routBitcoin took a sharp hit on Tuesday, falling in tandem with a broad sell-off in technology stocks that rattled global markets. The leading cryptocurrency dropped more than 5% in a single session,...
June 23, 2026 - 18:40
SpaceX stock dips below $150 debut before reboundingSpaceX`s stock took another hit on Tuesday, sliding below its initial public offering price of $150 before recovering later in the session. The sell-off extended a rough stretch for the company`s...
June 22, 2026 - 17:54
SpaceX stock tumbles 16.4%, shaving off most IPO gains since debutSpaceX shares took another sharp hit on Monday, putting the company on track for three consecutive days of losses. The steep decline has wiped out the majority of the gains the stock had racked up...
June 22, 2026 - 04:41
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth NarrativeWest Pharmaceutical Services (WST) stock has drawn attention after recent share price moves, with investors weighing its role in drug containment and delivery in relation to current valuation...